Relaxin, the relaxin-like factor and their receptors

Advances in Experimental Medicine and Biology

Volumn 612, Issue , 2007, Pages 14-25

  Schwabe, Christian ^a   Büllesbach, Erika E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LGR7; LGR8; RELAXIN; RELAXIN LIKE FACTOR; UNCLASSIFIED DRUG; INSULIN; LEYDIG INSULIN LIKE PROTEIN; LEYDIG INSULIN-LIKE PROTEIN; PROTEIN; RECEPTOR; RELAXIN RECEPTORS; RXFP2 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; BINDING SITE; CRYPTORCHISM; GENE DELETION; GUINEA PIG; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; ANIMAL; FEMALE; GENETICS; MALE; METABOLISM; MOUSE; PHYSIOLOGY; PREGNANCY; SIGNAL TRANSDUCTION;

CAVIA; MUS;

ANIMALS; CRYPTORCHIDISM; FEMALE; GENE DELETION; GUINEA PIGS; HUMANS; INSULIN; MALE; MICE; PREGNANCY; PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RELAXIN; SIGNAL TRANSDUCTION;

EID: 38749085688     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74672-2_2     Document Type: Review

References (50)

1. Hisaw FL. Experimental relaxation of the pubic ligament of the guinea pig. Proc Soc Exp Biol Med 1926; 23:661-663.
2. Adham IM, Burkhardt E, Benahmed M et al. Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. J Biol Chem 1993; 268:26668-26672.
3. Zimmermann S, Steding G, Emmen JM et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 1999; 13:681-691.
4. Nef S, Parada LF. Cryptorchidism in mice mutant for Insl.3 Nat Genet 1999; 22:295-299.
5. Overbeek PA, Gorlov IP, Sutherland RW et al. A transgenic insertion causing cryptorchidism in mice. Genesis 2001; 30:26-35.
6. Büllesbach EE, Schwabe C. A novel Leydig cell cDNA-derived protein is a relaxin-like factor (RLF). J Biol Chem 1995; 270:16011-16015.
7. Büllesbach EE, Schwabe C. Specific, high-affinity relaxin-like factor receptors. J Biol Chem 1999; 274:22354-22358.
8. Hsu SY, Nakabayashi K, Nishi S et al. Activation of orphan receptors by the hormone relaxin. Science 2002; 295:671-674.
9. Sherwood OD, O'Byrne EM. Purification and characterization of porcine relaxin. Arch Biochem Biophys 1974; 160:185-196.
10. Büllesbach EE, Schwabe C. Naturally occurring porcine relaxins and large-scale preparation of the B29 hormone. Biochemistry 1985; 24:7717-7722.
11. Canova-Davis E, Kessler TJ, Lee PJ et al. Use of recombinant DNA derived human relaxin to probe the structure of the native protein. Biochem 1991; 30:6006-6013.
12. Büllesbach EE, Schwabe C. Total synthesis of human relaxin and human relaxin derivatives by solid phase peptide synthesis and site-directed chain combination. J Biol Chem 1991; 266:10754-10761.
13. Schwabe C, Büllesbach E. Relaxin and the fine structure of proteins: R.G. Landers Co.; 1998.
14. Eigenbrot C, Randal M, Quan C et al. X-ray structure of human relaxin at 1.5 A: Comparison to insulin and implications for receptor binding determinants. J Mol Biol 1991; 221:15-21.
15. Reinig JW, Daniel LN, Schwabe C et al. Isolation and characterization of relaxin from the sand tiger shark (odontaspis taurus). Endocrinology 1981; 109:537-543.
16. Büllesbach EE, Schwabe C. On the receptor binding site of relaxin. Int. J Peptide Protein Res 1988; 32:361-367.
17. Büllesbach EE, Schwabe C. The functional importance of the A chain loop in relaxin and insulin. J Biol Chem 1994; 269:13124-13128.
18. Büllesbach EE, Schwabe C. The relaxin receptor binding site geometry suggests a novel gripping mode of interaction. J Biol Chem 2000; 275:35276-35280.
19. Kobe B, Deisenhofer J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 1993; 366:751-756.
20. Kobe B, Deisenhofer J. A structural basis of interactions between leucine-rich repeats and protein ligands. Nature 1995; 374:183-186.
21. Scott DJ, Layfield S, Yan Y et al. Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique LDLa modules. J Biol Chem 2006.
22. Büllesbach EE, Schwabe C. The trap-like relaxin-binding site of the leucine-rich G-protein-coupled receptor 7. J Biol Chem 2005; 280(14):14051-14056.
23. Brennand JE, Calder AA, Leitch CR et al. Recombinant human relaxin as a cervical ripening agent. Brit J Obst Gynaecol 1997; 104(7):775-780.
24. Dschietzig T, Stangl K. Relaxin: a pregnancy hormone as central player of body fluid and circular homeostasis. Cell Mol Life Sci 2003; 60:688-700.
25. Samuel CS, Unemori EN, Mookerjee I et al. Relaxin modulates cardiac fibroblast proliferation, differentiation and collagen production and reverses cardiac fibrosis in vivo. Endocrinology 2004; 145:4125-4133.
26. Seibold JR. Relaxin: lessons and limitations. Curr Rheumatol Rep 2002; 4:275-276.
27. Samuel CS, Zhao C, Bathgate RAD et al. Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis. FASEB J 2003; 17:121-.
28. Møller H, Prener H, Skakkebæk NE. Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy and genital malformations: Case control studies in Denmark. Cancer Causes Control 1996; 7:264-274.
29. John Radcliffe Hospital Cryptorchidism Study Group. Cryptorchidism: an apparent substantial increase since 1960. Br Med J 1986; 293:1401-1404.
30. Adham IM, Steding G, Thamm T et al. The overexpression of the INSL3 in female mice causes descent of the ovaries. Mol Endocrinology 2002; 16:244-252.
31. Boockfor FR, Fullbright G, Büllesbach EE et al. Relaxin-like factor (RLF) serum concentrations and gubemaculum RLF receptor-display in relation to pre- and neonatal development of rats. Reproduction 2001; 122:899-906.
32. Spiess AN, Balvert M, Tena-Sempere M et al. Structure and expression of the rat relaxin-like factor (RLF) gene. Mol Reprod Devel 1999; 54:319-325.
33. Büllesbach EE, Schwabe C. The primary structure and the disulfide links of the bovine relaxin-like factor (RLF). Biochemistry 2002; 41:274-281.
34. Burkhardt E, Adham IM, Hobohm U et al. A human cDNA coding for the Leydig insulin-like peptide (Ley I-L). Hum Genet 1994; 94:91-94.
35. Bathgate R, Balvers M, Hunt N et al. Relaxin-like factor gene is highly expressed in the bovine ovary of the cycle and pregnancy - Sequence and messenger ribonucleic acid analysis. Biol Reprod 1996; 55(6):1452-1457.
36. Pusch W, Balvers M, Ivell R. Molecular cloning and expression of the relaxin-like factor from the mouse testis. Endocrinology 1996; 137(7):3009-3013.
37. Roche PJ, Butkus A, Wintour EM et al. Structure and expression of Leydig insulin-like peptide mRNA in the sheep. Mol Cell Endocrinology 1996; 121(2):171-177.
38. Koskimies P, Spiess AN, Lahti P et al. The mouse relaxin-like factor gene and its promoter are located within the 3′region of the JAC3 genomic sequence. FEBS Lett 1997; 419:186-190.
39. Zimmermann S, Schottler P, Engel W et al. Mouse Leydig insulin-like (Ley I-L) gene - Structure and expression during testis and ovary development. Mol Reprod Develop 1997; 47(1):30-38.
40. Hombach-Klonisch S, Tetens F, Kauffold J et al. Molecular cloning and localization of caprine relaxin-like factor (RLF) mRNA within the goat testis. Mol Reprod Develop 1999; 53:135-141.
41. Hombach-Klonisch S, Kauffold J, Rautenberg T et al. Relaxin-like factor (RLF) mRNA expression in the fallow deer. Mol Cell Endocrinology 2000; 159:147-158.
42. Truong A, Bogatcheva NY, Schelling C et al. Isolation and expression analysis of the canine insulin-like factor 3 gene. Biol Reprod 2003; 69:1658-1664.
43. Büllesbach EE, Schwabe C. Tryptophan B27 in the relaxin-like factor (RLF) is crucial for RLF receptor binding. Biochemistry 1999; 38:3073-3078.
44. Büllesbach EE, Schwabe C. Synthetic cross-links arrest the C-terminal region of the relaxin-like factor (RLF) in an active conformation. Biochemistry 2004; 43:8021-8028.
45. Büllesbach EE, Schwabe C. The mode of interaction of the relaxin-like factor (RLF) with the leucine-rich repeat G protein-activated receptor 8. J Biol Chem 2006; 26136-26143.
46. Rosengren KJ, Zhang S, Lin F et al. Solution structure and characterization of the receptor binding surface of insulin-like peptide 3. J Biol Chem 2006; 28287-28295.
47. Del Borgo MP, Hughes RA, Bathgate RA et al. Analogs of insulin-like peptide 3 (INSL3) B-chain are LGR8 antagonists in vitro and in vivo. J Biol Chem 2006; 281(19):13068-13074.
48. Halls ML, Bond CP, Sudo S et al. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8). J Pharmacol Exp Ther 2005; 313(2):677-687.
49. Dawson NF, Tan YY, Macris M et al. Solid phase synthesis of ovine Leydig cell insulin-like peptide - a putative ovine relaxin? J Peptide Res 1999; 53:542-547.
50. Büllesbach EE, Schwabe C. LGR8 signal activation by the relaxin-like factor. J Biol Chem 2005; 280(15):14586-14590.